CBI’s Formulary, Co-Pay and Access Summit
April 5-6, 2016 | Philadelphia, PA
From the company that brought you the Coupon and Co-Pay Off-Set Strategies Series, CBI’s Formulary, Co-Pay and Access Summit provides a forum for industry to learn how to strategically navigate new access challenges, such as formulary exclusions, high deductible plans, NDC blocks and step therapy programs, while still providing valuable patient services and support, including coupons, co-pays or bridge programs.
Stakeholders providing expert insight include representatives from Acorda Therapeutics, Bayer, Biogen, Celldex Therapeutics, eMAX Health, Insys Therapeutics, Janssen, Novo Nordisk, Pfizer, PSKW and TrialCard.
Don’t miss this timely meeting designed to provide critical insights and solutions to the biggest obstacles in patient access and offer design.
For more information, please download the complete agenda or visit www.cbinet.com/formulary. Drug Channels readers will save $200 off of the standard registration rate when they use code DYQ363.*
*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates. Other restrictions may apply.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.